Veranova Appoints Cécile Maupas as Senior Vice President, Chief Commercial Officer

Veranova, a development and manufacturing of specialist and complex APIs for the pharmaceutical and biotech sectors, recently announced the appointment of Cécile Maupas as Senior Vice President, Chief Commercial Officer.

Cécile will join the executive team and assume responsibility for business development, marketing, project management, commercial operations, and product management. 

The news comes after Veranova recently announced expansion – estimated at $30 million – of its antibody-drug conjugate (ADC) and highly potent compound development and manufacturing capabilities.

A seasoned commercial and business executive, Cécile brings a deep understanding of contract development and manufacturing organizations (CDMO) and the pharmaceutical industry. Her proven track record of building teams and transforming organizations and extensive experience across multiple drug modalities will ensure Cécile is an integral part of Veranova’s continued growth.

“I’m delighted to have Cécile join the Veranova team as our Chief Commercial Officer” said Mike Riley, Chief Executive Officer of Veranova. “Her expertise and track record in building and growing businesses will be invaluable as Veranova continues to execute our strategy to build a world-class CDMO.”

Cécile Maupas, Senior Vice President, Chief Commercial Officer, Veranova. ©...
Cécile Maupas, Senior Vice President, Chief Commercial Officer, Veranova. © Veranova

Company

Logo:

Veranova

435 Devon Park Drive
19087 Wayne
US

Company contact







Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

most read

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.